In this paper, we aim to integrate our previous findings regarding IL-22-mediated hepatocyte proliferation and HCC progression to further describe an approach that could be utilized to balance simultaneous liver regeneration and suppressed tumor progression. This evidence concerns the gene IL22 and hepatocellular carcinoma.